112 related articles for article (PubMed ID: 29518423)
21. The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus.
López-Nevot MA; Ramal L; Jiménez-Alonso J; Martín J
Rheumatology (Oxford); 2003 Jan; 42(1):113-6. PubMed ID: 12509623
[TBL] [Abstract][Full Text] [Related]
22. Inducible nitric oxide synthase promoter polymorphism in human brucellosis.
Orozco G; Sánchez E; López-Nevot MA; Caballero A; Bravo MJ; Morata P; de Dios Colmenero J; Alonso A; Martín J
Microbes Infect; 2003 Nov; 5(13):1165-9. PubMed ID: 14623011
[TBL] [Abstract][Full Text] [Related]
23. Preliminary evidences of a NOS2A protective effect from relapsing-remitting multiple sclerosis.
Manna I; Liguori M; Valentino P; Condino F; La Russa A; Clodomiro A; Nisticò R; Di Palma G; Quattrone A
J Neurol Sci; 2008 Jan; 264(1-2):112-7. PubMed ID: 17854833
[TBL] [Abstract][Full Text] [Related]
24. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain.
Gonzalez-Gay MA; Llorca J; Sanchez E; Lopez-Nevot MA; Amoli MM; Garcia-Porrua C; Ollier WE; Martin J
Rheumatology (Oxford); 2004 Sep; 43(9):1182-5. PubMed ID: 15226517
[TBL] [Abstract][Full Text] [Related]
25. The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies.
Xu W; Liu L; Emson P; Harrington CR; McKeith IG; Perry RH; Morris CM; Charles IG
Neuroreport; 2000 Feb; 11(2):297-9. PubMed ID: 10674474
[TBL] [Abstract][Full Text] [Related]
26. Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis.
Gonzalez-Gay MA; Llorca J; Palomino-Morales R; Gomez-Acebo I; Gonzalez-Juanatey C; Martin J
Clin Exp Rheumatol; 2009; 27(1):116-9. PubMed ID: 19327239
[TBL] [Abstract][Full Text] [Related]
27. iNOS promoter variants and severe malaria in Ghanaian children.
Cramer JP; Mockenhaupt FP; Ehrhardt S; Burkhardt J; Otchwemah RN; Dietz E; Gellert S; Bienzle U
Trop Med Int Health; 2004 Oct; 9(10):1074-80. PubMed ID: 15482399
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease.
Senhaji N; Nadifi S; Zaid Y; Serrano A; Rodriguez DAL; Serbati N; Karkouri M; Badre W; Martín J
World J Gastroenterol; 2017 Dec; 23(47):8300-8307. PubMed ID: 29307990
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide synthase 2 (NOS2) promoter polymorphisms in colorectal cancer.
Fransén K; Elander N; Söderkvist P
Cancer Lett; 2005 Jul; 225(1):99-103. PubMed ID: 15922861
[TBL] [Abstract][Full Text] [Related]
30. Increased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter.
Tatemichi M; Sawa T; Gilibert I; Tazawa H; Katoh T; Ohshima H
Cancer Lett; 2005 Jan; 217(2):197-202. PubMed ID: 15617837
[TBL] [Abstract][Full Text] [Related]
31. CCTTT pentanucleotide repeats in inducible nitric oxide synthase gene expression in patients with pulmonary arterial hypertension.
Baloira Villar A; Pousada Fernández G; Vilariño Pombo C; Núñez Fernández M; Cifrián Martínez J; Valverde Pérez D
Arch Bronconeumol; 2014 Apr; 50(4):141-5. PubMed ID: 24439467
[TBL] [Abstract][Full Text] [Related]
32. The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers.
Ryk C; Hou SM; Pershagen G; Wiklund NP; Nyberg F; de Verdier PJ
Tumour Biol; 2014 May; 35(5):4425-34. PubMed ID: 24408018
[TBL] [Abstract][Full Text] [Related]
33. Genetic determinants of rheumatoid arthritis: the inducible nitric oxide synthase (NOS2) gene promoter polymorphism.
Pascual M; López-Nevot MA; Cáliz R; Koeleman BP; Balsa A; Pascual-Salcedo D; Martín J
Genes Immun; 2002 Aug; 3(5):299-301. PubMed ID: 12140750
[TBL] [Abstract][Full Text] [Related]
34. Inducible nitric oxide synthase genetic polymorphism and risk of asbestosis.
Franko A; Dodič-Fikfak M; Arnerić N; Dolžan V
J Biomed Biotechnol; 2011; 2011():685870. PubMed ID: 21660141
[TBL] [Abstract][Full Text] [Related]
35. Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk.
Shen CH; Wang YH; Wang WC; Jou YC; Hsu HS; Hsieh HY; Chiou HY
Urology; 2007 May; 69(5):1001-6. PubMed ID: 17482959
[TBL] [Abstract][Full Text] [Related]
36. Variants of NOS1, NOS2, and NOS3 genes in asthmatics.
Gao PS; Kawada H; Kasamatsu T; Mao XQ; Roberts MH; Miyamoto Y; Yoshimura M; Saitoh Y; Yasue H; Nakao K; Adra CN; Kun JF; Moro-oka S; Inoko H; Ho LP; Shirakawa T; Hopkin JM
Biochem Biophys Res Commun; 2000 Jan; 267(3):761-3. PubMed ID: 10673365
[TBL] [Abstract][Full Text] [Related]
37. Cytosolic phospholipase A2 group IVA is overexpressed in patients with persistent asthma and regulated by the promoter microsatellites.
Sokolowska M; Stefanska J; Wodz-Naskiewicz K; Cieslak M; Pawliczak R
J Allergy Clin Immunol; 2010 Jun; 125(6):1393-5. PubMed ID: 20392485
[No Abstract] [Full Text] [Related]
38. Functional variants in NOS1 and NOS2A are not associated with progressive hearing loss in Ménière's disease in a European Caucasian population.
Gazquez I; Lopez-Escamez JA; Moreno A; Campbell CA; Meyer NC; Carey JP; Minor LB; Gantz BJ; Hansen MR; Della Santina CC; Aran I; Soto-Varela A; Santos S; Batuecas A; Perez-Garrigues H; Lopez-Nevot A; Smith RJ; Lopez-Nevot MA
DNA Cell Biol; 2011 Sep; 30(9):699-708. PubMed ID: 21612410
[TBL] [Abstract][Full Text] [Related]
39. NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity.
Kawaguchi Y; Tochimoto A; Hara M; Kawamoto M; Sugiura T; Katsumata Y; Okada J; Kondo H; Okubo M; Kamatani N
Arthritis Res Ther; 2006; 8(4):R104. PubMed ID: 16813666
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in the promoter region of iNOS predispose to rheumatoid arthritis in south Indian Tamils.
Negi VS; Mariaselvam CM; Misra DP; Muralidharan N; Fortier C; Charron D; Krishnamoorthy R; Tamouza R
Int J Immunogenet; 2017 Jun; 44(3):114-121. PubMed ID: 28374504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
